Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Motor System Impairment Device Evaluates Tremors

By Labmedica staff writers
Posted on 23 Jan 2008
A device is being developed that will allow doctors to easily evaluate the degree and type of the tremors caused in the upper limbs by some neurologic disorders.

Called a Dimeter, the system makes it easier for doctors and other health professionals to objectively evaluate the tremors exhibited in the hands and fingers of patients affected by some disorders that impair their motor skills, such as Parkinson, amyotrophic lateral sclerosis, or Charcot-Marie-Tooth disease.

The device uses an electromechanical apparatus that is controlled by the hand or finger of the affected patient and registers the movement and the forces that are generated. More...
Together with a computer monitor, doctors execute a series of virtual static and motion tests, such as trying to keep the hand at rest, or describing a set movement, like a straight line or a spiral. In any of these tests, a weight can be added to the patient to evaluate the effect on the tremor while the system constantly monitors and records each movement.

The computer gathers the data and processes it to provide the doctor with the information needed for the patient's evaluation in a numeric or graphic format to the level of detail required. This report is objective and precise and enables doctors to adjust their diagnosis of the condition and monitor the progression of the disease, or the effectiveness of the treatment.

The device was developed by scientists from the Universidad Politécnica de Madrid (UPM; Madrid, Spain) and colleagues Antonio Barrientos and Roberto González from the Grupo de Investigación en Robótica y Cibernética of the UPM, with the collaboration of the Centro Estatal de Autonomía Personal y Ayudas Técnicas (CEAPAT) of the Instituto de Mayores y Servicios Sociales (IMSERSO; Ceuta, Spain)


Related Links:
Universidad Politécnica de Madrid
Instituto de Mayores y Servicios Sociales

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.